Catalyst OrthoScience Names Carl O’Connell as President and CEO
Catalyst OrthoScience Inc. (Catalyst), a medical device company focused on the upper extremity orthopedics market, has named Carl O’Connell as president and chief executive officer effective immediately.
O’Connell replaces Brian Hutchison, who is stepping down. Hutchison joined the company as executive chairman and interim CEO in June 2018 before being asked to stay on as CEO later that same year. He remains a significant investor in the company and will serve as an advisor as needed.
“We are pleased to have Carl step in as president and CEO of Catalyst OrthoScience,” said Carter McNabb, managing director at RC Capital (fka River Cities Capital) and a member of the Catalyst board of directors. “We thank Brian for the work he has done to build this company to where it is today.”
“I am excited to join the Catalyst team and continue the company’s trajectory of significant, sustainable growth,” said O’Connell. “I will be focused on ensuring a smooth transition for our employees, our distributors and our customers over the coming months. I look forward to the commercial launch and expansion of the Archer™ R1 Reverse Shoulder System, as well as continuing to enhance our product portfolio to maintain Catalyst’s leadership position in the marketplace.”
Click here to read more.